Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
In vitro mechanistic study of a small molecule binding to mutant p53 domains, with no cell-based or clinical data, raising a question about therapeutic potential rather than demonstrating it.
This is a journal commentary synthesizing two concurrent primary studies; it raises mechanistic questions about ATR's role in EMT and metastasis but does not itself present original empirical data or a definitive clinical trial result.
Sound experimental study in 3D models demonstrating that DNA damage response inhibitors enhance radiosensitivity to both X-rays and proton therapy, but limited to in vitro spheroids without clinical validation or human data.
Mechanistic and proof-of-concept work in vitro and in a murine model identifying a drug repurposing opportunity; lacks human efficacy data and clinical validation needed to support practice change.
Mechanistic study identifying a synthetic lethal interaction and demonstrating in vivo tumor suppression, but limited to cell lines and xenografts without clinical efficacy data.